X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower
ZOLL MEDICAL CORPORATION · Decision date Oct 2, 2026
What did the FDA decide?
ZOLL Medical Corporation filed a 30-Day Notice, supplement S054 to PMA P160022, recorded with decision OK30 on 2026-10-02. The database lists the change as "an alternate electrode manufacturing line" under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The named device grouping covers X Series, R Series, AED Pro and AED 3 BLS professional defibrillators, the Pro-Padz Radiotransparent Electrode and SurePower, within the non-wearable automated external defibrillator category (product code MKJ).
The S054 identifier frames this as a supplement to the existing PMA rather than an original approval, and a manufacturing notice does not constitute approval of the whole system. The database field does not identify which electrode or component the alternate line produces, its location, qualification data, or any FDA review finding beyond the stated decision code; the notice's purpose should not be read as independent evidence of safety or clinical effectiveness. Whether the alternate line applies to Pro-Padz, another electrode, or the defibrillator units themselves is absent.
FDA approval order statement
an alternate electrode manufacturing line
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 2, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P160022/S054
- Regulatory pathway
- PMA supplement
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- MKJ
- Decision code
- OK30
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Automated external defibrillators (non-wearable).
- Applicant
- ZOLL MEDICAL CORPORATION
- Product code
- MKJ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P160022. Subsequent supplements may change the device or its indications.
FDA decision timeline
P160022 · Original PMA
X Series, R Series, AED Pro, AED 3 BLS Professional Defibrillators, Pro-Padz Radiotransparent Electrode, SurePower
P160022/S054 received
Application receipt date recorded by FDA.
P160022/S054 · FDA decision
30-Day Notice
P160022/S056 · Related supplement
ZOLL R Series Monitor/Defibrillator
Timeline entries are records held by MedtechLedger for P160022. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P160022
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ZOLL MEDICAL CORPORATION | PMA approval | Dec 27, 2017 | FDA | |
ZOLL R Series Monitor/DefibrillatorP160022/S056 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
Explore the linked device profile
Other records with product code MKJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
LIFEPAK 35 monitor/defibrillatorP160026/S076 | Physio-Control, Inc. | PMA supplement | Oct 29, 2026 | FDA |
AED 3 Defibrillator with Uni-PadzP160015/S029 | ZOLL MEDICAL CORPORATION | PMA supplement | Oct 16, 2026 | FDA |
| Physio-Control, Inc. | PMA supplement | Sep 24, 2026 | FDA | |
LIFEPAK 15 monitor/defibrillatorP160026/S073 | Physio-Control, Inc. | PMA supplement | Sep 10, 2026 | FDA |
LIFEPAK 35 monitor/defibrillatorP160026/S069 | Physio-Control, Inc. | PMA supplement | Sep 2, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
ZOLL MEDICAL CORPORATION
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 269 & 271 Mill Rd., Chelsmford, MA, 01824
Sources and methodology
- Original FDA record: P160022/S054
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



